Improving HIV treatment adherence for stimulant-using men
Supporting Treatment Adherence for Resilience and Thriving (START): A mHealth intervention to improve ART adherence for HIV-positive stimulant-using men
This study is testing a helpful mobile program called START that supports HIV-positive men who use stimulants in sticking to their medication, and it's for those who might find it hard to get regular healthcare.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Florida International University NIH-funded |
| Lab location | 1 site (Miami, United States) |
| Project ID | NIH-10895784 on NIH RePORTER |
What this research studies
This research investigates a mobile health intervention called START, designed to help HIV-positive men who use stimulants adhere to their antiretroviral therapy (ART). The program aims to improve health outcomes by providing support and resources through a mobile platform, particularly for those who may struggle to access traditional healthcare services. Participants will be randomly assigned to either the START intervention or a control group that receives standard information about HIV treatment and substance use resources. The effectiveness of the intervention will be measured by tracking viral load suppression over six months and assessing whether these improvements are sustained after one year.
Who could benefit from this research
Good fit: Ideal candidates for this research are HIV-positive men who use stimulants and may have difficulty accessing HIV care services.
Not a fit: Patients who do not use stimulants or are not HIV-positive may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better health outcomes for HIV-positive stimulant users by increasing their adherence to treatment and reducing viral loads.
How similar studies have performed: Previous research has shown that mobile health interventions can effectively improve treatment adherence in various populations, suggesting potential success for this approach.
Where this research is happening
Miami, United States
- Florida International University — Miami, United States (Active)
Researchers
- Principal investigator: Carrico, Adam Wayne — Florida International University
- Study coordinator: Carrico, Adam Wayne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.